India to United States: Lenalidomide Export Trade Route
India has recorded 112 verified shipments of Lenalidomide exported to United States, representing a combined trade value of $853.4M USD. This corridor is served by 12 active Indian exporters, with an average shipment value of $7.6M USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 56% of total export value with 25 shipments worth $475.2M USD. On the buying side, SUN PHARMACEUTICAL INDUSTRIES,INC. is the largest importer in United States with $190.9M USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, DR REDDYS LABORATORIES LIMITED — together control 91% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Lenalidomide corridor is one of India's established pharmaceutical export routes, with 112 shipments documented worth a combined $853.4M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 56% of all export value, reflecting the consolidated nature of India's lenalidomide manufacturing sector.
Across 12 active suppliers, the average shipment value stands at $7.6M USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with lenalidomide's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 19.7%, placing it at rank #6 among India's top lenalidomide export destinations globally.
On the import side, key buyers of Indian lenalidomide in United States include SUN PHARMACEUTICAL INDUSTRIES,INC., DR REDDYS LABORATORIES INC, SUN PHARMACEUTICAL INDUSTRIESINC. and 19 others. SUN PHARMACEUTICAL INDUSTRIES,INC. is the single largest importer with 7 shipments valued at $190.9M USD.
Route Characteristics
- Average transit28 days
- Peak seasonQ1
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#6
- Annual growth+19.7%
- Demand growth+18.7%
- Regulatory ease83/100
Top 10 Indian Lenalidomide Exporters to United States
Showing top 10 of 12 Indian suppliers exporting Lenalidomide to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $19.0M per shipment | 25 | $475.2M | 55.7% |
| 2 | EUGIA PHARMA SPECIALITIES LIMITED Avg $3.3M per shipment | 52 | $170.6M | 20.0% |
| 3 | DR REDDYS LABORATORIES LIMITED Avg $130.5M per shipment | 1 | $130.5M | 15.3% |
| 4 | CIPLA LIMITED Avg $19.2M per shipment | 4 | $77.0M | 9.0% |
| 5 | NATCO PHARMA LIMITED Avg $65.4K per shipment | 3 | $196.1K | 0.0% |
| 6 | MYLAN LABORATORIES LIMITED Avg $6.4K per shipment | 4 | $25.4K | 0.0% |
| 7 | ATLAS ENTERPRISES Avg $358 per shipment | 11 | $3.9K | 0.0% |
| 8 | MYGENIC HEALTHCARE PRIVATE LIMITED Avg $954 per shipment | 3 | $2.9K | 0.0% |
| 9 | VINAYAK ASSOCIATES Avg $194 per shipment | 5 | $971 | 0.0% |
| 10 | KOIT BIOPHARMA PRIVATE LIMITED Avg $480 per shipment | 1 | $480 | 0.0% |
This table shows the top 10 of 12 Indian companies exporting lenalidomide to United States, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, DR REDDYS LABORATORIES LIMITED, CIPLA LIMITED, NATCO PHARMA LIMITED, MYLAN LABORATORIES LIMITED, ATLAS ENTERPRISES, MYGENIC HEALTHCARE PRIVATE LIMITED, VINAYAK ASSOCIATES, KOIT BIOPHARMA PRIVATE LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 25 shipments worth $475.2M USD, giving it a 56% market share. The top 3 suppliers together account for 91% of the total trade value on this route.
Showing top 10 of 12 total Indian exporters on the India to United States Lenalidomide export route.
Top 10 Lenalidomide Importers in United States
Showing top 10 of 22 known buyers in United States receiving Lenalidomide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian lenalidomide in United States include SUN PHARMACEUTICAL INDUSTRIES,INC., DR REDDYS LABORATORIES INC, SUN PHARMACEUTICAL INDUSTRIESINC., AUROBINDO PHARMA USA., INC,, SUN PHARMACEUTICAL INDUSTRIES INC, among 22 total buyers. The largest importer is SUN PHARMACEUTICAL INDUSTRIES,INC., accounting for $190.9M USD across 7 shipments — representing 22% of all lenalidomide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES,INC. | 7 | $190.9M | 22.4% |
| 2 | DR REDDYS LABORATORIES INC | 1 | $130.5M | 15.3% |
| 3 | SUN PHARMACEUTICAL INDUSTRIESINC. | 8 | $126.6M | 14.8% |
| 4 | AUROBINDO PHARMA USA., INC, | 38 | $114.8M | 13.5% |
| 5 | SUN PHARMACEUTICAL INDUSTRIES INC | 7 | $100.8M | 11.8% |
| 6 | CIPLA USA INC UPS SUPPLY CHAIN SOL | 4 | $77.0M | 9.0% |
| 7 | AUROBINDO PHARMA USA INC | 13 | $52.2M | 6.1% |
| 8 | SUN PHARMACEUTICAL INDUSTRIES,INC.. | 2 | $49.4M | 5.8% |
| 9 | 2 INDEPENDENCE WAY PRINCETON NJ | 1 | $7.4M | 0.9% |
| 10 | AUROBINDO PHARMA USA., INC | 1 | $3.6M | 0.4% |
Showing top 10 of 22 Lenalidomide importers in United States on this route.
Top 10 Lenalidomide Formulations Imported by United States
Showing top 10 of 96 product formulations shipped on the India to United States Lenalidomide route, ranked by trade value
United States imports a wide range of lenalidomide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — LENALIDOMIDE CAPS 25MG US 21S BOTTLE — accounts for $130.5M USD across 1 shipments. There are 96 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LENALIDOMIDE CAPS 25MG US 21S BOTTLE | 1 | $130.5M | 15.3% |
| 2 | LENALIDOMIDE CAPSULES 10 MG 28C USA (PACK : 28 CAPSULE) | 2 | $85.4M | 10.0% |
| 3 | LENALIDOMIDE CAPSULES 10MG [3960 PACK X28 CAPSULES] | 1 | $43.5M | 5.1% |
| 4 | LENALIDOMIDE CAPSULES 15 MG 21C USA (PACK : 21 CAPSULE) | 2 | $41.1M | 4.8% |
| 5 | LENALIDOMIDE CAP 10 MG 28C USA BATCH DND2033A MFD 03 12 2022 EXP 30 11 2024 | 1 | $38.5M | 4.5% |
| 6 | LENALIDOMIDE CAPSULES 5 MG 28C USA (PACK: 28 CAPSULE) | 1 | $35.4M | 4.1% |
| 7 | LENALIDOMIDE CAPSULES 10 MG (ACT. QTY. 2856PACK X 28 CAPSULE)NOS | 1 | $33.1M | 3.9% |
| 8 | LENALIDOMIDE CAPSULES 10 MG (ACT. QTY. 2520PACK X 28CAPSULE)NOS | 1 | $29.2M | 3.4% |
| 9 | LENALIDOMIDE CAPSULES 5 MG (ACT. QTY. 2448 PACK X 28CAPSULE)NOS | 1 | $28.3M | 3.3% |
| 10 | LENALIDOMIDE 10 MG CAPS ; NDC# 69097-382-73;ANDA# 210435 (4320 PACKSX 28'S=120960 NOS) | 1 | $27.5M | 3.2% |
Showing top 10 of 96 Lenalidomide formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 79%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 20 shipments. Transit time averages 28 days by sea.
Market Dynamics
India's lenalidomide exports to United States are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 25 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 12 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, DR REDDYS LABORATORIES LIMITED — together account for 91% of total trade value on this route. The average shipment value of $7.6M USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as lenalidomide capsules 10 mg 28c usa (pack : 28 capsule) and lenalidomide capsules 10mg [3960 pack x28 capsules], suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, SUN PHARMACEUTICAL INDUSTRIES,INC. is the largest importer with 7 shipments worth $190.9M USD — representing 22% of all lenalidomide imports from India on this route. A total of 22 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $853.4M
- Avg. Shipment
- $7.6M
- Suppliers
- 12
- Buyers
- 22
- Transit (Sea)
- ~28 days
- Annual Growth
- +19.7%
Related Analysis
Reverse Direction
United States → India — Lenalidomide (Import)Other Lenalidomide Routes
Unlock the Full India to United States Lenalidomide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 112 shipments on this route.
Frequently Asked Questions — India to United States Lenalidomide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Lenalidomide to United States?
The leading Indian exporters of Lenalidomide to United States are SUN PHARMACEUTICAL INDUSTRIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, DR REDDYS LABORATORIES LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 56% of total trade value on this route.
Q What is the total value of Lenalidomide exports from India to United States?
India exports Lenalidomide to United States worth approximately $853.4M USD across 112 recorded shipments. The average value per shipment is $7.6M USD.
Q Which ports does India use to ship Lenalidomide to United States?
The most active port of origin is SAHAR AIR with 20 shipments. Indian exporters primarily use sea freight for this route, with 79% of shipments going by sea and 26% by air.
Q How long does shipping take from India to United States for Lenalidomide?
The average transit time for Lenalidomide shipments from India to United States is approximately 28 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United States Lenalidomide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 19.7% with demand growth tracking at 18.7%. The route is ranked #6 among India's top Lenalidomide export destinations globally.
Q How many suppliers are active on the India to United States Lenalidomide route?
There are currently 12 active Indian suppliers exporting Lenalidomide to United States. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 56% of total shipment value.
Q Who are the main importers of Lenalidomide from India in United States?
The leading importers of Indian Lenalidomide in United States include SUN PHARMACEUTICAL INDUSTRIES,INC., DR REDDYS LABORATORIES INC, SUN PHARMACEUTICAL INDUSTRIESINC., AUROBINDO PHARMA USA., INC,, SUN PHARMACEUTICAL INDUSTRIES INC. SUN PHARMACEUTICAL INDUSTRIES,INC. is the largest buyer with 7 shipments worth $190.9M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Lenalidomide.
- 2.Supplier/Buyer Matching: 12 Indian exporters and 22 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 112 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
112 Verified Shipments
12 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists